Avidity Biosciences Inc
RNA
Market Cap$3.52B
Close$
$-1.60
105.5% downside
Current Fair Value
105.5% downsideOvervalued by 105.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.52 Billion |
|---|---|
| Enterprise Value | $3.28 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.89 |
| Beta | 0.95 |
| Outstanding Shares | 129,232,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -10.21 |
|---|---|
| PEG | -14.98 |
| Price to Sales | - |
| Price to Book Ratio | 2.92 |
| Enterprise Value to Revenue | 367.63 |
| Enterprise Value to EBIT | -7.57 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data